top of page

Siemens DCA Vantage

SKU: Siemens DCA Vantage
  • The DCA Vantage® Analyzer provides lab-accurate results for monitoring glycemic control in patients with diabetes and conducting annual checks for kidney disease. ​

  • CLIA-waived HbA1c test results in minutes with just a 1 µL whole-blood fingerstick sample

  • Urinary albumin-to-creatinine ratio (ACR) for early detection of kidney disease

  • ADDITIONAL INFORMATION

    DCA Vantage Analyzer Improve Patient Care while Decreasing Costs

    DCA, DCA Vantage, Point of Care Ecosystem, and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands are the property of their respective owners.

    Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.

    The outcomes achieved by the Siemens Healthineers customers described here were achieved in each customer‘s unique setting. Since there is no typical hospital, and many variables exist (e.g., hospital size, case mix, level of IT adoption), there can be no guarantee that others will achieve the same results.

    Product Configurations and Reimbursement Codes

    Item Configuration Part Number CPT Codes
    DCA Vantage Analyzer 1 each 10282969 n/a
    DCA® HbA1c Test Kits 10 tests 10311134 HbA1c (83036 QW*)
    DCA HbA1c Controls 4 vials 10311161 n/a
    DCA Microalbumin/ Creatinine Test Kits 10 tests 10311480 Urine Microalbumin (82043) Creatinine (82570)
    DCA Microalbumin/ Creatinine Controls 4 vials 10325406 n/a

     


    Connectivity-Ready Analyzer

    Flexible connectivity options to transfer data from the DCA Vantage Analyzer to the EMR/ EHR, LIS/HIS system of your choice. Get data where you need it and keep your POC testing program in control and audit-ready.

     


    The DCA Vantage® Analyzer provides lab-accurate results for monitoring glycemic control in patients with diabetes and conducting annual checks for kidney disease.

    •  CLIA-waived HbA1c test results in minutes with just a 1 µL whole-blood fingerstick sample
    • Urinary albumin-to-creatinine ratio (ACR) for early detection of kidney disease


    Increase Efficiency while Decreasing Costs

    The DCA Vantage Analyzer can help you:

    • Improve patient compliance by providing immediate feedback and allowing therapy adjustments during the patient visit.
    •  Improve and meet diabetes quality measures and leverage payer incentive programs.


    Improve Clinical Outcomes
    By reducing HbA1c

    Availability of POC A1c testing impacts HbA1c levels in both the short term (<1.5 years) and the longer term.

    Increase Patient Satisfaction
    With actionable results in minutes

    Patient satisfaction scores improve with point-of-care diabetes testing.

    Reduce Costs
    By increasing practice efficiency

    The DCA Vantage Analyzer can reduce the need for follow-up phone calls and letters and potentially reduce associated costs.


    “POCT can significantly improve clinical operations with cost reductions through improved practice efficiency. The economic benefits of POCT may be realized in both fee-for-service and global payment environments.” 

  • DOWNLOADABLE PDF

Order products like this and more call 305-593-2137 or fill out the form below.

Contact us

bottom of page